首页> 外文期刊>MedChemComm >Dual mode of action of phenyl-pyrazole-phenyl (6-5-6 system)-based PPI inhibitors: Alpha-helix backbone versus alpha-helix binding epitope
【24h】

Dual mode of action of phenyl-pyrazole-phenyl (6-5-6 system)-based PPI inhibitors: Alpha-helix backbone versus alpha-helix binding epitope

机译:基于苯基-吡唑-苯基(6-5-6系统)的PPI抑制剂的双重作用方式:α-螺旋骨架与α-螺旋结合表位

获取原文
获取原文并翻译 | 示例
           

摘要

A new class of alpha-helix mimetics, based on the phenyl-pyrazole-phenyl (6-5-6) system, has been designed and synthesized. The ability of the new compounds to inhibit PPIs was confirmed using an MDM2-p53 binding assay. The library, containing completely new compounds, revealed an excellent hit rate of 15%, had satisfactory physicochemical properties (~38% soluble compounds), and the ligand efficiency of the best compound was 0.21 (0.22 for nutlin-3 in the same assay). Dual mode of action of these inhibitors was suggested based on computer modeling: depending on the nature of their substituents they could act as either an alpha-helix backbone mimetic or an alpha-helix binding epitope mimetic.
机译:设计并合成了基于苯基-吡唑-苯基(6-5-6)系统的新型α-螺旋模拟物。使用MDM2-p53结合测定法确认了新化合物抑制PPI的能力。包含全新化合物的文库显示出15%的优异命中率,具有令人满意的理化特性(〜38%可溶化合物),最佳化合物的配体效率为0.21(同一试验中nutlin-3的配比为0.22)。 。根据计算机模型,提出了这些抑制剂的双重作用方式:根据其取代基的性质,它们可以充当α-螺旋骨架模拟物或α-螺旋结合表位模拟物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号